Year Book of Urology 2011

1. Cover - p. 1 2. Contents - p. 2 3. Chapter 1: Effect of Amitriptyline on Symptoms in Treatment Naïve Patients With Interstitial Cystitis/Painful Bladder Syndrome - p. 6 4. Chapter 2: A short biodegradable helical spiral ureteric stent provides better antireflux and drainage properties than a double-J stent - p. 7 5. One Week of Nitrofurantoin Before Percutaneous Nephrolithotomy Significantly Reduces Upper Tract Infection and Urosepsis: A Prospective Controlled Study - p. 8 6. Tubeless Procedure is Most Important Factor in Reducing Length of Hospitalization After Percutaneous Nephrolithotomy: Results of Univariable and Multivariable Models - p. 9 7. Complications of Stone Baskets: 14-Year Review of the Manufacturer and User Facility Device Experience Database - p. 10 8. YouTube as a Source of Information on Kidney Stone Disease - p. 11 9. Shock Wave Lithotripsy is Not Predictive of Hypertension Among Community Stone Formers at Long-Term Followup - p. 12 10. A Prospective Randomised Trial Comparing the Modified HM3 with the MODULITH® SLX-F2 Lithotripter - p. 13 11. Chapter 3: Laparoscopic Live Donor Nephrectomy with Vaginal Extraction: Initial Report - p. 14 12. Embolization of Polycystic Kidneys as an Alternative to Nephrectomy Before Renal Transplantation: A Pilot Study - p. 15 13. Robotic-Assisted Laparoscopic Donor Nephrectomy with Transvaginal Extraction of the Kidney - p. 16 14. Chapter 4: Differences in continence system between community-dwelling black and white women with and without urinary incontinence in the EPI study - p. 17 15. A Randomized, Controlled Trial Comparing an Innovative Single Incision Sling With an Established Transobturator Sling to Treat Female Stress Urinary Incontinence - p. 18 16. Improving Urinary Incontinence in Overweight and Obese Women Through Modest Weight Loss - p. 19 17. Update of AUA Guideline on the Surgical Management of Female Stress Urinary Incontinence - p. 20 18. Outcomes after anterior vaginal wall repair with mesh: a randomized, controlled trial with a 3 year follow-up - p. 21 19. Trocar-guided mesh repair of vaginal prolapse using partially absorbable mesh: 1 year outcomes - p. 22 20. Anterior Colporrhaphy versus Transvaginal Mesh for Pelvic-Organ Prolapse - p. 23 21. Efficacy and Tolerability of Fesoterodine in Older and Younger Subjects With Overactive Bladder - p. 24 22. Efficacy and Safety of OnabotulinumtoxinA for Idiopathic Overactive Bladder: A Double-Blind, Placebo Controlled, Randomized, Dose Ranging Trial - p. 25 23. Midterm Prospective Evaluation of TVT-Secur Reveals High Failure Rate - p. 26 24. Randomized Trial of Tension-Free Vaginal Tape and Tension-Free Vaginal Tape-Obturator for Urodynamic Stress Incontinence in Women - p. 27 25. A randomised controlled trial comparing TVT, Pelvicol and autologous fascial slings for the treatment of stress urinary incontinence in women - p. 28 26. Retropubic versus Transobturator Midurethral Slings for Stress Incontinence - p. 29 27. Retropubic versus Transobturator Midurethral Slings for Stress Incontinence - p. 30 28. Risk of Infection After Midurethral Synthetic Sling Surgery: Are Postoperative Antibiotics Necessary? - p. 31 29. Chapter 5: Natural History of Renal Cortical Neoplasms During Active Surveillance With Follow-up Longer Than 5 Years - p. 32 30. Irreversible Electroporation of Renal Cell Carcinoma: A First-in-Man Phase I Clinical Study - p. 33 31. Initial Series of Robotic Radical Nephrectomy with Vena Caval Tumor Thrombectomy - p. 34 32. Chronic Kidney Disease Before and After Partial Nephrectomy - p. 35 33. The Impact of Cytoreductive Nephrectomy on Survival of Patients With Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Targeted Therapy - p. 36 34. A Prospective, Randomised EORTC Intergroup Phase 3 Study Comparing the Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma - p. 37 35. Laparoscopic Techniques Applied to Open Surgery: Sliding-clip Renorrhaphy - p. 38 36. Intraoperative Conversion From Partial to Radical Nephrectomy at a Single Institution From 2003 to 2008 - p. 39 37. Can partial nephrectomy preserve renal function and modify survival in comparison with radical nephrectomy? - p. 40 38. Chapter 6: Patient-specific risk of undetected malignant disease after investigation for haematuria, based on a 4-year follow-up - p. 41 39. Contemporary Use of Perioperative Cisplatin-Based Chemotherapy in Patients With Muscle-Invasive Bladder Cancer - p. 42 40. Detection and Clinical Outcome of Urinary Bladder Cancer With 5-Aminolevulinic Acid-Induced Fluorescence Cystoscopy: A Multicenter Randomized, Double-Blind, Placebo-Controlled Trial - p. 43 41. Chapter 7: PCA3 Molecular Urine Test for Predicting Repeat Prostate Biopsy Outcome in Populations at Risk: Validation in the Placebo Arm of the Dutasteride REDUCE Trial - p. 44 42. Comorbidity and Mortality Results From a Randomized Prostate Cancer Screening Trial - p. 45 43. An Empirical Evaluation of Guidelines on Prostate-specific Antigen Velocity in Prostate Cancer Detection - p. 46 44. Prediction of Significant Prostate Cancer Diagnosed 20 to 30 Years Later With a Single Measure of Prostate-Specific Antigen at or Before Age 50 - p. 47 45. Randomised prostate cancer screening trial: 20 year follow-up - p. 48 46. Mortality results from the Göteborg randomised population-based prostate-cancer screening trial - p. 49 47. Effects of Prostate-Specific Antigen Testing on Familial Prostate Cancer Risk Estimates - p. 50 48. Coffee Consumption and Prostate Cancer Risk and Progression in the Health Professionals Follow-up Study - p. 51 49. Active Surveillance Compared With Initial Treatment for Men With Low-Risk Prostate Cancer: A Decision Analysis - p. 52 50. Prevalence and Significance of Fluoroquinolone Resistant Escherichia coli in Patients Undergoing Transrectal Ultrasound Guided Prostate Needle Biopsy - p. 53 51. Immediate Risk of Suicide and Cardiovascular Death After a Prostate Cancer Diagnosis: Cohort Study in the United States - p. 54 52. The genomic complexity of primary human prostate cancer - p. 55 53. Comparative Effectiveness of Prostate Cancer Treatments: Evaluating Statistical Adjustments for Confounding in Observational Data - p. 56 54. Comparative Risk-Adjusted Mortality Outcomes After Primary Surgery, Radiotherapy, or Androgen-Deprivation Therapy for Localized Prostate Cancer - p. 57 55. Analysis of Pathologic Extent of Disease for Clinically Localized Prostate Cancer After Radical Prostatectomy and Subsequent Use of Adjuvant Radiation in a National Cohort - p. 58 56. Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer - p. 59 57. Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: A randomised, double-blind study - p. 60 58. Active Surveillance Program for Prostate Cancer: An Update of the Johns Hopkins Experience - p. 61 59. Outcomes in Localized Prostate Cancer: National Prostate Cancer Register of Sweden Follow-up Study - p. 62 60. Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study - p. 63 61. Recovery of Erectile Function After Nerve Sparing Radical Prostatectomy and Penile Rehabilitation With Nightly Intraurethral Alprostadil Versus Sildenafil Citrate - p. 64 62. Annual Surgical Caseload and Open Radical Prostatectomy Outcomes: Improving Temporal Trends - p. 65 63. Coronary Revascularization and Mortality in Men With Congestive Heart Failure or Prior Myocardial Infarction Who Receive Androgen Deprivation - p. 66 64. Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study - p. 67 65. Risk of colorectal cancer in men on long-term androgen deprivation therapy for prostate cancer - p. 68 66. Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer - p. 69 67. Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years - p. 70 68. The Impact of Prostate Biopsy and Periprostatic Nerve Block on Erectile and Voiding Function: A Prospective Study - p. 71 69. Chapter 8: Randomized Trials in 2466 Patients With Stage I Seminoma: Patterns of Relapse and Follow-up - p. 72 70. Chapter 9: Long-Term Infection Outcomes After Original Antibiotic Impregnated Inflatable Penile Prosthesis Implants: Up to 7.7 Years of Followup - p. 73 71. Identification of Late-Onset Hypogonadism in Middle-Aged and Elderly Men - p. 74 72. The Dopamine Transporter Gene (DAT1) Polymorphism is Associated with Premature Ejaculation - p. 75 73. Effect of Angiotensin II and its Receptor Antagonists on Human Corpus Cavernous Contractility and Oxidative Stress: Modulation of Nitric Oxide Mediated Relaxation - p. 76 74. Hypercholesterolemia-Induced Erectile Dysfunction: Endothelial Nitric Oxide Synthase (eNOS) Uncoupling in the Mouse Penis by NAD(P)H Oxidase - p. 77 75. Atorvastatin improves the response to sildenafil in hypercholesterolemic men with erectile dysfunction not initially responsive to sildenafil - p. 78 76. Is Testosterone a Friend or a Foe of the Prostate? - p. 79 77. Physical Activity and PDE5 Inhibitors in the Treatment of Erectile Dysfunction: Results of a Randomized Controlled Study - p. 80 78. Adverse Events Associated with Testosterone Administration - p. 81 79. Adipose Tissue-Derived Stem Cells Secrete CXCL5 Cytokine with Neurotrophic Effects on Cavernous Nerve Regeneration - p. 82 80. Testosterone Levels and Quality of Life in Diverse Male Patients With Cancers Unrelated to Androgens - p. 83 81. Can Low-Intensity Extracorporeal Shockwave Therapy Improve Erectile Function? A 6-Month Follow-up Pilot Study in Patients with Organic Erectile Dysfunction - p. 84 82. A Cross-Sectional Study for the Analysis of Clinical, Sexual and Laboratory Conditions Associated to Peyronie's Disease - p. 85 83. Role for Tyrosine Kinases in Contraction of Rat Penile Small Arteries - p. 86 84. Amyloid β Precursor Protein Regulates Male Sexual Behavior - p. 87 85. Predicting Erectile Function Recovery after Bilateral Nerve Sparing Radical Prostatectomy: A Proposal of a Novel Preoperative Risk Stratification - p. 88 86. Investigation of the Neural Target Level of Hyperthyroidism in Premature Ejaculation in a Rat Model of Pharmacologically Induced Ejaculation - p. 89 87. Potential Mechanism of Action of Human Growth Hormone on Isolated Human Penile Erectile Tissue - p. 90 88. T-786C Polymorphism in Promoter of eNOS Gene as Genetic Risk Factor in Patients With Erectile Dysfunction in Turkish Population - p. 91 89. Erectile Dysfunction Drug Receipt, Risky Sexual Behavior and Sexually Transmitted Diseases in HIV-infected and HIV-uninfected Men - p. 92 90. Upregulation of gp91phox Subunit of NAD(P)H Oxidase Contributes to Erectile Dysfunction Caused by Long-term Nitric Oxide Inhibition in Rats: Reversion by Regular Physical Training - p. 93 91. The Effects of Beta-blockers on Endothelial Nitric Oxide Synthase Immunoreactivity in the Rat Corpus Cavernosum - p. 94 92. Characterization of the Effects of Various Drugs Likely to Affect Smooth Muscle Tension on Isolated Human Seminal Vesicle Tissue - p. 95 93. A Multicenter, Double-blind, Placebo-controlled Trial to Assess The Efficacy of Sildenafil Citrate in Men With Unrecognized Erectile Dysfunction - p. 96 94. Molecular Mechanisms of Vacuum Therapy in Penile Rehabilitation: A Novel Animal Study - p. 97 95. Activated RhoA/Rho Kinase Impairs Erectile Function After Cavernous Nerve Injury in Rats - p. 98 96. Genome-wide association study to identify single nucleotide polymorphisms (SNPS) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer - p. 99 97. Exposure of Human Seminal Vesicle Tissue to Phosphodiesterase (PDE) Inhibitors Antagonizes the Contraction Induced by Norepinephrine and Increases Production of Cyclic Nucleotides - p. 100 98. Pentoxifylline Promotes Recovery of Erectile Function in a Rat Model of Postprostatectomy Erectile Dysfunction - p. 101 99. Long-Term Infection Outcomes After Original Antibiotic Impregnated Inflatable Penile Prosthesis Implants: Up to 7.7 Years of Followup - p. 102 100. Relationship of Asymmetric Dimethylarginine With Penile Doppler Ultrasound Parameters in Men with Vasculogenic Erectile Dysfunction - p. 103 101. Regular Nonsteroidal Anti-Inflammatory Drug Use and Erectile Dysfunction - p. 104 102. Effect of Intensive Glycemic Therapy on Erectile Function in Men With Type 1 Diabetes - p. 105 103. The Management of Peyronie's Disease: Evidence-based 2010 Guidelines - p. 106 104. Effects of Testosterone Undecanoate on Cardiovascular Risk Factors and Atherosclerosis in Middle-Aged Men with Late-Onset Hypogonadism and Metabolic Syndrome: Results from a 24-month, Randomized, Double-Blind, Placebo-Controlled Study - p. 107 105. Adherence to Mediterranean Diet and Erectile Dysfunction in Men with Type 2 Diabetes - p. 108 106. Association of Episodic Physical and Sexual Activity With Triggering of Acute Cardiac Events: Systematic Review and Meta-analysis - p. 109 107. Five-Year Follow-Up of Peyronie's Graft Surgery: Outcomes and Patient Satisfaction - p. 110 108. The Effect of Intracavernous Injection of Adipose Tissue-Derived Stem Cells on Hyperlipidemia-Associated Erectile Dysfunction in a Rat Model - p. 111 109. Genetic and Environmental Influences on Self-Reported G-Spots in Women: A Twin Study - p. 112 110. Radiofrequency Treatment of Vaginal Laxity after Vaginal Delivery: Nonsurgical Vaginal Tightening - p. 113 111. Effects of exposure to a mobile phone on sexual behavior in adult male rabbit: an observational study - p. 114 112. A Protein Tyrosine Kinase Inhibitor, Imatinib Mesylate (Gleevec), Improves Erectile and Vascular Function Secondary to a Reduction of Hyperglycemia in Diabetic Rats - p. 115 113. Is Obesity a Further Cardiovascular Risk Factor in Patients with Erectile Dysfunction? - p. 116 114. Time Course of Recovery of Erectile Function After Radical Retropubic Prostatectomy: Does Anyone Recover After 2 Years? - p. 117 115. Adherence to Mediterranean Diet and Sexual Function in Women with Type 2 Diabetes - p. 118 116. Activation of NMDA Receptors in Lumbar Spinothalamic Cells is Required for Ejaculation - p. 119 117. Morphological and Functional Evidence for the Contribution of the Pudendal Artery in Aging-Induced Erectile Dysfunction - p. 120 118. Improved Ejaculatory Latency, Control and Sexual Satisfaction When PSD502 is Applied Topically in Men with Premature Ejaculation: Results of a Phase III, Double-Blind, Placebo-Controlled Study - p. 121 119. Intracavernous Delivery of Synthetic Angiopoietin-1 Protein as a Novel Therapeutic Strategy for Erectile Dysfunction in the Type II Diabetic db/db Mouse - p. 122 120. The Role of PDE5 Inhibitors in Penile Septal Scar Remodeling: Assessment of Clinical and Radiological Outcomes - p. 123 121. Bioengineered corporal tissue for structural and functional restoration of the penis - p. 124 122. Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials - p. 125 123. Smoking-Cessation and Adherence Intervention Among Chinese Patients with Erectile Dysfunction - p. 126 124. Sexually Transmitted Diseases Among Users of Erectile Dysfunction Drugs: Analysis of Claims Data - p. 127 125. The use of high-resolution magnetic resonance imaging in the management of patients presenting with priapism - p. 128 126. Oral L-Citrulline Supplementation Improves Erection Hardness in Men With Mild Erectile Dysfunction - p. 129 127. Impact of nasal polyposis on erectile dysfunction - p. 130 128. The effects of three phosphodiesterase type 5 inhibitors on ejaculation latency time in lifelong premature ejaculators: a double-blind laboratory setting study - p. 131 129. Characterizing Behavior of Corpus Cavernosum in Chloride-free Condition - p. 132 130. Chapter 10: Tissue-engineered autologous urethras for patients who need reconstruction: an observational study - p. 133 131. Developing biodegradable scaffolds for tissue engineering of the urethra - p. 134 132. Chapter 11: Long-Term Complications of Conduit Urinary Diversion - p. 135 133. Intermediate Term Outcomes Associated With the Surveillance of Ureteropelvic Junction Obstruction in Adults - p. 136 134. Irrigation of Continent Catheterizable Ileal Pouches: Tap Water Can Replace Sterile Solutions Because It Is Safe, Easy, and Economical - p. 137 135. Pelvic endometriosis and hydroureteronephrosis - p. 138 136. Chapter 12: Children and youth with myelomeningocele's independence in managing clean intermittent catheterization in familiar settings - p. 139 137. Irrigation of Continent Catheterizable Ileal Pouches: Tap Water Can Replace Sterile Solutions Because It Is Safe, Easy, and Economical - p. 140 138. Imaging-Guided Suprapubic Bladder Tube Insertion: Experience in the Care of 549 Patients - p. 141 139. Intravesical Electromotive Botulinum Toxin Type A Administration—Part II: Clinical Application - p. 142 140. Urodynamic Profile of Diabetic Patients With Lower Urinary Tract Symptoms: Association of Diabetic Cystopathy With Autonomic and Peripheral Neuropathy - p. 143 141. A 20-year follow-up of the mesh wallstent in the treatment of detrusor external sphincter dyssynergia in patients with spinal cord injury - p. 144 142. Chapter 13: Comparison of Bladder Outlet Procedures Without Augmentation in Children With Neurogenic Incontinence - p. 145 143. Chapter 14: The Swedish Reflux Trial in Children: I. Study Design and Study Population Characteristics - p. 146 144. The Swedish Reflux Trial in Children: II. Vesicoureteral Reflux Outcome - p. 147 145. The Swedish Reflux Trial in Children: III. Urinary Tract Infection Pattern - p. 148 146. The Swedish Reflux Trial in Children: V. Bladder Dysfunction - p. 149 147. The Swedish Reflux Trial in Children: IV. Renal Damage - p. 150 148. High Grade Primary Vesicoureteral Reflux in Boys: Long-Term Results of a Prospective Cohort Study - p. 151 149. Pediatric Vesicoureteral Reflux Guidelines Panel Summary Report: Clinical Practice Guidelines for Screening Siblings of Children With Vesicoureteral Reflux and Neonates/Infants With Prenatal Hydronephrosis - p. 152 150. Summary of the AUA Guideline on Management of Primary Vesicoureteral Reflux in Children - p. 153 151. Chapter 15: Treatment for Postprostatectomy Incontinence: Is This as Good as It Gets? - p. 154 152. Patient-reported reasons for discontinuing overactive bladder medication - p. 155 153. Complications of the AdVance Transobturator Male Sling in the Treatment of Male Stress Urinary Incontinence - p. 156 154. Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity - p. 157 155. Chapter 16: Low Dose Oral Desmopressin for Nocturnal Polyuria in Patients With Benign Prostatic Hyperplasia: A Double-Blind, Placebo Controlled, Randomized Study - p. 158 156. Chapter 17: International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial - p. 159 157. Treatment of Muscle Invasive Bladder Cancer: Evidence From the National Cancer Database, 2003 to 2007 - p. 160 158. A Population-Based Competing-Risks Analysis of the Survival of Patients Treated With Radical Cystectomy for Bladder Cancer - p. 161 159. Chapter 18: Intra-Abdominal Testis: Histological Alterations and Significance of Biopsy - p. 162 160. Modified Scrotal (Bianchi) Mid Raphe Single Incision Orchiopexy for Low Palpable Undescended Testis: Early Outcomes - p. 163 161. Diagnostic Performance of Ultrasound in Nonpalpable Cryptorchidism: A Systematic Review and Meta-analysis - p. 164 162. The testicular regression syndrome—do remnants require routine excision? - p. 165 163. Chapter 19: Sexual Function and Surgical Outcome in Women with Congenital Adrenal Hyperplasia Due to CYP21A2 Deficiency: Clinical Perspective and the Patients' Perception - p. 166 164. Should Male Gender Assignment be Considered in the Markedly Virilized Patient With 46,XX and Congenital Adrenal Hyperplasia? - p. 167 165. Chapter 20: Management of hypospadias cripples with two-staged Bracka's technique - p. 168 166. Critical Outcome Analysis of Staged Buccal Mucosa Graft Urethroplasty for Prior Failed Hypospadias Repair in Children - p. 169 167. Water Consumption and Use, Trihalomethane Exposure, and the Risk of Hypospadias - p. 170 168. Chapter 21: Finasteride-associated male infertility - p. 171 169. Chapter 22: Predicting the Need for Radiologic Imaging in Adults with Febrile Urinary Tract Infection - p. 172 170. Cranberry Juice Fails to Prevent Recurrent Urinary Tract Infection: Results From a Randomized Placebo-Controlled Trial - p. 173 171. Cranberry Juice Fails to Prevent Recurrent Urinary Tract Infection: Results From a Randomized Placebo-Controlled Trial - p. 174 172. Executive Summary: International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases - p. 175 173. A program to limit urinary catheter use at an acute care hospital - p. 176 174. No increased risk of adverse pregnancy outcomes in women with urinary tract infections: a nationwide population-based study - p. 177 175. Chapter 23: Imaging Strategy for Infants With Urinary Tract Infection: A New Algorithm - p. 178 176. Febrile Infants With Urinary Tract Infections at Very Low Risk for Adverse Events and Bacteremia - p. 179 177. 5-Year Prospective Results of Dimercapto-Succinic Acid Imaging in Children With Febrile Urinary Tract Infection: Proof That the Top-Down Approach Works - p. 180 178. Chapter 24: Assessment of Parental Satisfaction in Children Undergoing Voiding Cystourethrography Without Sedation - p. 181 179. Chapter 25: Are Antibiotics Necessary for Pediatric Epididymitis? - p. 182 180. Chapter 26: Overprescription of Postoperative Narcotics: A Look at Postoperative Pain Medication Delivery, Consumption and Disposal in Urological Practice - p. 183 181. Evaluating an Evidence-Based Bundle for Preventing Surgical Site Infection: A Randomized Trial - p. 184 182. Chapter 27: A Survey of Ethically Challenging Issues in Urological Practice - p. 185 183. Chapter 28: A Conservative Approach to Testicular Rupture in Adolescent Boys - p. 186 184. Instituting a Conservative Management Protocol for Pediatric Blunt Renal Trauma: Evaluation of a Prospectively Maintained Patient Registry - p. 187 185. Intermediate-Term Follow-Up of Patients Treated With Percutaneous Embolization for Grade 5 Blunt Renal Trauma - p. 188 186. Revision of Current American Association for the Surgery of Trauma Renal Injury Grading System - p. 189 187. Chapter 29: Does Varicocele Repair Improve Male Infertility? An Evidence-Based Perspective From a Randomized, Controlled Trial - p. 190 188. Percutaneous retrograde endovascular occlusion for pediatric varicocele - p. 191